{
    "nctId": "NCT00625742",
    "title": "An Exploratory Trial of a Multimodal Treatment Strategy for Cancer Cachexia",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "referred to the Cachexia Clinic with involuntary weight loss of >5% of their premorbid weight within the previous 6 months"
                    },
                    {
                        "type": "variable",
                        "value": "18 years of age or older"
                    },
                    {
                        "type": "variable",
                        "value": "Karnofsky performance score of 60 or higher"
                    },
                    {
                        "type": "variable",
                        "value": "can maintain oral food intake during the study"
                    },
                    {
                        "type": "variable",
                        "value": "can understand the study procedures and can sign an informed consent form"
                    },
                    {
                        "type": "not",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "currently taking melatonin"
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "taking megestrol acetate and continue to lose weight despite at least 2 weeks of therapy"
                    },
                    {
                        "type": "variable",
                        "value": "calculated creatinine clearance of >= 60 cc/min"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "have dementia or delirium (as determined by the palliative care specialist) at study entry"
                            },
                            {
                                "type": "variable",
                                "value": "are pregnant"
                            },
                            {
                                "type": "variable",
                                "value": "have been taking corticosteroids for longer than 48 hours"
                            },
                            {
                                "type": "variable",
                                "value": "have pulmonary edema, ascites or pitting edema on clinical examination"
                            },
                            {
                                "type": "variable",
                                "value": "are unable to walk"
                            },
                            {
                                "type": "variable",
                                "value": "have a history of serious adverse gastrointestinal events (i.e., bleeding or perforation), history of a coagulopathy or current anti-coagulant use"
                            },
                            {
                                "type": "variable",
                                "value": "have an ALT/AST >3x upper limit of normal"
                            },
                            {
                                "type": "variable",
                                "value": "patients on methotrexate"
                            },
                            {
                                "type": "variable",
                                "value": "patients taking melatonin receptor agonists (such as Rozerem\u00ae [ramelteon])"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('18 years of age or older'), Symbol('Karnofsky performance score of 60 or higher'), Symbol('calculated creatinine clearance of >= 60 cc/min'), Symbol('can maintain oral food intake during the study'), Symbol('can understand the study procedures and can sign an informed consent form'), Symbol('referred to the Cachexia Clinic with involuntary weight loss of >5% of their premorbid weight within the previous 6 months'), Symbol('taking megestrol acetate and continue to lose weight despite at least 2 weeks of therapy'), Not(Symbol('currently taking melatonin')), Not(Or(Symbol('are pregnant'), Symbol('are unable to walk'), Symbol('have a history of serious adverse gastrointestinal events (i.e., bleeding or perforation), history of a coagulopathy or current anti-coagulant use'), Symbol('have an ALT/AST >3x upper limit of normal'), Symbol('have been taking corticosteroids for longer than 48 hours'), Symbol('have dementia or delirium (as determined by the palliative care specialist) at study entry'), Symbol('have pulmonary edema, ascites or pitting edema on clinical examination'), Symbol('patients on methotrexate'), Symbol('patients taking melatonin receptor agonists (such as Rozerem\u00ae [ramelteon])'))))"
}